Document:

exv10w1

 

Exhibit 10.1

PERLEGEN SCIENCES, INC.

INDEMNIFICATION AGREEMENT

     THIS AGREEMENT is entered into, effective as of                     , 2006 by and between Perlegen
Sciences, Inc., a Delaware corporation (the “Company”), and                     
(“Indemnitee”), effective as of the date that the Registration Statement on Form S-1
related to the initial public offering of the Company’s Common Stock is declared effective by the
United States Securities and Exchange Commission.

     WHEREAS, it is essential to the Company to retain and attract as directors and officers the
most capable persons available;

     WHEREAS, Indemnitee is a director and/or officer of the Company;

     WHEREAS, both the Company and Indemnitee recognize the increased risk of litigation and other
claims currently being asserted against directors and officers of corporations;

     WHEREAS, the Certificate of Incorporation and Bylaws of the Company require the Company to
indemnify and advance expenses to its directors and officers to the fullest extent permitted under
Delaware law, and the Indemnitee has been serving and continues to serve as a director and/or
officer of the Company in part in reliance on the Company’s Certificate of Incorporation and
Bylaws; and

     WHEREAS, in recognition of Indemnitee’s need for (i) substantial protection against personal
liability based on Indemnitee’s reliance on the aforesaid Certificate of Incorporation and Bylaws,
(ii) specific contractual assurance that the protection promised by the Certificate of
Incorporation and Bylaws will be available to Indemnitee (regardless of, among other things, any
amendment to or revocation of the Certificate of Incorporation and Bylaws or any change in the
composition of the Company’s Board of Directors or acquisition transaction relating to the Company)
and (iii) an inducement to provide effective services to the Company as a director and/or officer,
the Company wishes to provide in this Agreement for the indemnification of and the advancing of
expenses to Indemnitee to the fullest extent (whether partial or complete) permitted under Delaware
law and as set forth in this Agreement, and, to the extent insurance is maintained, to provide for
the continued coverage of Indemnitee under the Company’s directors’ and officers’ liability
insurance policies.

     NOW, THEREFORE, in consideration of the above premises and of Indemnitee continuing to serve
the Company directly or, at its request, with another enterprise, and intending to be legally bound
hereby, the parties agree as follows:

          1. Certain Definitions:

               (a) “Board” shall mean the Board of Directors of the Company.

 

 

               (b) “Affiliate” shall mean any corporation or other person or entity that directly, or
indirectly through one or more intermediaries, controls or is controlled by or is under common
control with, the person specified, including, without limitation, with respect to the Company, any
direct or indirect subsidiary of the Company.

               (c) A “Change in Control” shall be deemed to have occurred if (i) any “person” (as
such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”)) (other than a trustee or other fiduciary holding securities under an
employee benefit plan of the Company or a corporation owned directly or indirectly by the
stockholders of the Company in substantially the same proportions as their ownership of stock of
the Company, and other than any person holding shares of the Company on the date that the Company
first registers under the Act or any transferee of such individual if such transferee is a spouse
or lineal descendant of the transferee or a trust for the benefit of the individual, his or her
spouse or lineal descendants), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under
the Exchange Act), directly or indirectly, of securities of the Company representing 30% or more of
the total voting power represented by the Company’s then outstanding Voting Securities, (ii) during
any period of two consecutive years, individuals who at the beginning of such period constitute the
Board and any new director whose election by the Board or nomination for election by the Company’s
stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in
office who either were directors at the beginning of the period or whose election or nomination for
election was previously so approved, cease for any reason to constitute a majority of the Board,
(iii) the stockholders of the Company approve a merger or consolidation of the Company with any
other entity, other than a merger or consolidation that would result in the Voting Securities of
the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into Voting Securities of the surviving entity) at least 80% of
the total voting power represented by the Voting Securities of the Company or such surviving entity
outstanding immediately after such merger or consolidation or (iv) the stockholders of the Company
approve a plan of complete liquidation of the Company or an agreement for the sale or disposition
by the Company (in one transaction or a series of transactions) of all or substantially all of the
Company’s assets.

               (d) “Expenses” shall mean any expense, liability or loss, including attorneys’ fees,
judgments, fines, ERISA excise taxes and penalties, amounts paid or to be paid in settlement, any
interest, assessments or other charges imposed thereon, any federal, state, local or foreign taxes
imposed as a result of the actual or deemed receipt of any payments under this Agreement and all
other costs and obligations, paid or incurred in connection with investigating, defending, being a
witness in, participating in (including on appeal) or preparing for any of the foregoing in, any
Proceeding relating to any Indemnifiable Event.

               (e) “Indemnifiable Event” shall mean any event or occurrence that takes place either
prior to or after the execution of this Agreement, related to the fact that Indemnitee is or was a
director or officer of the Company or an Affiliate of the Company, or while a director or officer
is or was serving at the request of the Company or an Affiliate of the Company as a director,
officer, employee, trustee, agent or fiduciary of another foreign or domestic corporation,
partnership,

-2-

 

joint venture, employee benefit plan, trust or other enterprise or was a director, officer,
employee or agent of a foreign or domestic corporation that was a predecessor corporation of the
Company or of another enterprise at the request of such predecessor corporation, or related to
anything done or not done by Indemnitee in any such capacity, whether or not the basis of the
Proceeding is alleged action in an official capacity as a director, officer, employee or agent or
in any other capacity while serving as a director, officer, employee or agent of the Company or an
Affiliate of the Company, as described above.

               (f) “Independent Counsel” shall mean the person or body appointed in connection with
Section 3.

               (g) “Proceeding” shall mean any threatened, pending or completed action, suit or
proceeding or any alternative dispute resolution mechanism (including an action by or in the right
of the Company or an Affiliate of the Company) or any inquiry, hearing or investigation, whether
conducted by the Company or an Affiliate of the Company or any other party, that Indemnitee in good
faith believes might lead to the institution of any such action, suit or proceeding, whether civil,
criminal, administrative, investigative or other.

               (h) “Reviewing Party” shall mean the person or body appointed in accordance with
Section 3.

               (i) “Voting Securities” shall mean any securities of the Company that vote generally
in the election of directors.

          2. Agreement to Indemnify.

               (a) General Agreement. In the event Indemnitee was, is or becomes a party to or
witness or other participant in, or is threatened to be made a party to or witness or other
participant in, a Proceeding by reason of (or arising in part out of) an Indemnifiable Event, the
Company shall indemnify Indemnitee from and against any and all Expenses to the fullest extent
permitted by law, as the same exists or may hereafter be amended or interpreted (but in the case of
any such amendment or interpretation, only to the extent that such amendment or interpretation
permits the Company to provide broader indemnification rights than were permitted prior thereto).
The parties hereto intend that this Agreement shall provide for indemnification in excess of that
expressly permitted by statute, including, without limitation, any indemnification provided by the
Company’s Certificate of Incorporation, its Bylaws, vote of its stockholders or disinterested
directors or applicable law.

               (b) Initiation of Proceeding. Notwithstanding anything in this Agreement to the
contrary, Indemnitee shall not be entitled to indemnification pursuant to this Agreement in
connection with any Proceeding initiated by Indemnitee against the Company or any director or
officer of the Company unless (i) the Company has joined in or the Board has consented to the
initiation of such Proceeding, (ii) the Proceeding is one to enforce indemnification rights under
Section 5 or (iii) the Proceeding is instituted after a Change in Control (other than a Change in
Control approved by a majority of the directors on the Board who were directors immediately prior
to such Change in Control) and Independent Counsel has approved its initiation.

-3-

 

               (c) Expense Advances. If so requested by Indemnitee, the Company shall advance
(within thirty (30) days of such request) any and all Expenses to Indemnitee (an “Expense
Advance”). The Indemnitee shall qualify for such Expense Advances upon the execution and delivery
to the Company of this Agreement which shall constitute an undertaking providing that the
Indemnitee undertakes to repay such Expense Advances if and to the extent that it is ultimately
determined by a court of competent jurisdiction in a final judgment, not subject to appeal, that
Indemnitee is not entitled to be indemnified by the Company. Indemnitee’s obligation to reimburse
the Company for Expense Advances shall be unsecured and no interest shall be charged thereon. This
Section 2(c) shall not apply to any claim made by Indemnitee for which indemnity is excluded
pursuant to Section 2(b) or 2(f).

               (d) Mandatory Indemnification. Notwithstanding any other provision of this Agreement,
to the extent that Indemnitee has been successful on the merits or otherwise in defense of any
Proceeding relating in whole or in part to an Indemnifiable Event or in defense of any issue or
matter therein, Indemnitee shall be indemnified against all Expenses incurred in connection
therewith.

               (e) Partial Indemnification. If Indemnitee is entitled under any provision of this
Agreement to indemnification by the Company for some or a portion of Expenses, but not, however,
for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion
thereof to which Indemnitee is entitled.

               (f) Prohibited Indemnification. No indemnification pursuant to this Agreement shall
be paid by the Company on account of any Proceeding in which a final judgment is rendered against
Indemnitee or Indemnitee enters into a settlement, in each case (i) for an accounting of profits
made from the purchase or sale by Indemnitee of securities of the Company pursuant to the
provisions of Section 16(b) of the Exchange Act or similar provisions of any federal, state or
local laws; (ii) for which payment has actually been made to or on behalf of Indemnitee under any
insurance policy or other indemnity provision, except with respect to any excess beyond the amount
paid under any insurance policy or other indemnity provision; or (iii) for which payment is
prohibited by law. Notwithstanding anything to the contrary stated or implied in this Section
2(f), indemnification pursuant to this Agreement relating to any Proceeding against Indemnitee for
an accounting of profits made from the purchase or sale by Indemnitee of securities of the Company
pursuant to the provisions of Section 16(b) of the Exchange Act or similar provisions of any
federal, state or local laws shall not be prohibited if Indemnitee ultimately establishes in any
Proceeding that no recovery of such profits from Indemnitee is permitted under Section 16(b) of the
Exchange Act or similar provisions of any federal, state or local laws.

          3. Reviewing Party. Prior to any Change in Control, the Reviewing Party shall be any
appropriate person or body consisting of a member or members of the Board or any other person or
body appointed by the Board who is not a party to the particular Proceeding with respect to which
Indemnitee is seeking indemnification; provided that if all members of the Board are parties

-4-

 

to the
particular Proceeding with respect to which Indemnitee is seeking indemnification, the Independent
Counsel referred to below shall become the Reviewing Party; after a Change in Control, the
Independent Counsel referred to below shall become the Reviewing Party. With respect to all
matters arising before a Change in Control for which Independent Counsel shall be the Reviewing
Party and all matters arising after a Change in Control, in each case concerning the rights of
Indemnitee to indemnity payments and Expense Advances under this Agreement or any other agreement
or under applicable law or the Company’s Certificate of Incorporation or Bylaws now or hereafter in
effect relating to indemnification for Indemnifiable Events, the Company shall seek legal advice
only from Independent Counsel selected by Indemnitee and approved by the Company (which approval
shall not be unreasonably withheld or delayed), and who has not otherwise performed services for
the Company or the Indemnitee (other than in connection with indemnification matters) within the
last five years. The Independent Counsel shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in
representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under
this Agreement. Such counsel, among other things, shall render its written opinion to the Company
and Indemnitee as to whether and to what extent the Indemnitee should be permitted to be
indemnified under applicable law. The Company agrees to pay the reasonable fees of the Independent
Counsel and to indemnify fully such counsel against any and all expenses (including attorneys’
fees), claims, liabilities, loss and damages arising out of or relating to this Agreement or the
engagement of Independent Counsel pursuant hereto.

          4. Indemnification Process and Appeal.

               (a) Indemnification Payment. Indemnitee shall be entitled to indemnification of
Expenses, and shall receive payment thereof, from the Company in accordance with this Agreement as
soon as practicable after Indemnitee has made written demand on the Company for indemnification,
but in no event later than thirty (30) business days after demand, unless the Reviewing Party has
given a written opinion to the Company that Indemnitee is not entitled to indemnification under
applicable law. Indemnitee shall cooperate with the Reviewing Party making a determination with
respect to Indemnitee’s entitlement to indemnification, including providing to the Reviewing Party
upon reasonable advance request any documentation or information which is not privileged or
otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably
necessary to such determination.

               (b) Suit to Enforce Rights. Regardless of any action by the Reviewing Party, if
Indemnitee has not received full indemnification within thirty (30) days after making a demand in
accordance with Section 4(a), Indemnitee shall have the right to enforce its indemnification rights
under this Agreement by commencing litigation in any court in the State of California or the State
of Delaware having subject matter jurisdiction thereof seeking an initial determination by the
court or challenging any determination by the Reviewing Party or any aspect thereof. The Company
hereby consents to service of process and to appear in any such proceeding. Any determination by
the Reviewing Party not challenged by the Indemnitee shall be binding on the Company and
Indemnitee. The Company shall be precluded from asserting in any such proceeding that the
procedures and presumptions of this Agreement are not valid, binding and enforceable and

-5-

 

shall
stipulate in any such court that the Company is bound by all the provisions of this Agreement. The
remedy provided for in this Section 4 shall be in addition to any other remedies available to
Indemnitee at law or in equity.

               (c) Defense to Indemnification, Burden of Proof, and Presumptions. It shall be a
defense to any action brought by Indemnitee against the Company to enforce this
Agreement (other than an action brought to enforce a claim for Expenses incurred in defending
a Proceeding in advance of its final disposition) that it is not permissible under applicable law
for the Company to indemnify Indemnitee for the amount claimed. In connection with any such action
or any determination by the Reviewing Party or otherwise as to whether Indemnitee is entitled to be
indemnified hereunder, the burden of proving such a defense or determination shall be on the
Company. Neither the failure of the Reviewing Party or the Company (including its Board,
independent legal counsel or its stockholders) to have made a determination prior to the
commencement of such action by Indemnitee that indemnification of the claimant is proper under the
circumstances because Indemnitee has met the standard of conduct set forth in applicable law, nor
an actual determination by the Reviewing Party or Company (including its Board, independent legal
counsel or its stockholders) that the Indemnitee had not met such applicable standard of conduct,
shall be a defense to the action or create a presumption that the Indemnitee has not met the
applicable standard of conduct. For purposes of this Agreement, the termination of any claim,
action, suit or proceeding, by judgment, order, settlement (whether with or without court
approval), conviction or upon a plea of nolo contendere or its equivalent, shall not create a
presumption that Indemnitee did not meet any particular standard of conduct or have any particular
belief or that a court has determined that indemnification is not permitted by applicable law. For
purposes of any determination of good faith under any applicable standard of conduct, Indemnitee
shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books
of account of the Company, including financial statements, or on information supplied to Indemnitee
by the officers of the Company in the course of their duties, or on the advice of legal counsel for
the Company or the Board or counsel selected by any committee of the Board or on information or
records given or reports made to the Company by an independent certified public accountant or by an
appraiser, investment banker or other expert selected with reasonable care by the Company or the
Board or any committee of the Board. The provisions of the preceding sentence shall not be deemed
to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be
deemed to have met the applicable standard of conduct. The knowledge and/or actions, or failure to
act, or any director, officer, agent or employee of the Company shall not be imputed to Indemnitee
for purposes of determining the right to indemnification under this Agreement.

          5. Indemnification for Expenses Incurred in Enforcing Rights. The Company shall
indemnify Indemnitee against any and all Expenses that are incurred by Indemnitee in connection
with any action brought by Indemnitee for

                  (i) indemnification or advance payment of Expenses by the Company under this Agreement or any
other agreement or under applicable law or the Company’s Certificate of Incorporation or Bylaws now
or hereafter in effect relating to indemnification for Indemnifiable Events, and/or

-6-

 

                  (ii) recovery under directors’ and officers’ liability insurance policies maintained by the
Company; but only in the event that Indemnitee ultimately is determined to be entitled to such
indemnification or insurance recovery, as the case may be. In addition, the Company shall, if so
requested by Indemnitee, advance the foregoing Expenses to Indemnitee, subject to and in accordance
with Section 2(c).

          6. Notification and Defense of Proceeding.

               (a) Notice. Promptly after receipt by Indemnitee of notice of the commencement of any
Proceeding, Indemnitee shall, if a claim in respect thereof is to be made against the Company under
this Agreement, notify the Company of the commencement thereof; but the omission so to notify the
Company will not relieve the Company from any liability that it may have to Indemnitee, except as
provided in Section 6(c).

               (b) Defense. With respect to any Proceeding as to which Indemnitee notifies the
Company of the commencement thereof, the Company will be entitled to participate in the Proceeding
at its own expense and except as otherwise provided below, to the extent the Company so wishes, it
may assume the defense thereof with counsel reasonably satisfactory to Indemnitee. After notice
from the Company to Indemnitee of its election to assume the defense of any Proceeding, the Company
shall not be liable to Indemnitee under this Agreement or otherwise for any Expenses subsequently
incurred by Indemnitee in connection with the defense of such Proceeding other than reasonable
costs of investigation or as otherwise provided below. Indemnitee shall have the right to employ
legal counsel in such Proceeding, but all Expenses related thereto incurred after notice from the
Company of its assumption of the defense shall be at Indemnitee’s expense unless: (i) the
employment of legal counsel by Indemnitee has been authorized by the Company, (ii) Indemnitee has
reasonably determined that there may be a conflict of interest between Indemnitee and the Company
in the defense of the Proceeding, (iii) after a Change in Control, the employment of counsel by
Indemnitee has been approved by the Independent Counsel or (iv) the Company shall not in fact have
employed counsel to assume the defense of such Proceeding, in each of which cases all Expenses of
the Proceeding shall be borne by the Company. The Company shall not be entitled to assume the
defense of any Proceeding brought by or on behalf of the Company, or as to which Indemnitee shall
have made the determination provided for in (ii) above or under the circumstances provided for in
(iii) and (iv) above.

               (c) Settlement of Claims. The Company shall not be liable to indemnify Indemnitee
under this Agreement or otherwise for any amounts paid in settlement of any Proceeding effected
without the Company’s written consent, such consent not to be unreasonably withheld; provided,
however, that if a Change in Control has occurred, the Company shall be liable for indemnification
of Indemnitee for amounts paid in settlement if the Independent Counsel has approved the
settlement. The Company shall not settle any Proceeding in any manner that would impose any penalty
or limitation on Indemnitee without Indemnitee’s written consent. The Company shall not be liable
to indemnify the Indemnitee under this Agreement with regard to any judicial award if the Company
was not given a reasonable and timely opportunity as a result of Indemnitees’ failure to provide
notice, at its expense, to participate in the defense of such action, and

-7-

 

the lack of such notice
materially prejudiced the Company’s ability to participate in defense of such action. The
Company’s liability hereunder shall not be excused if participation in the Proceeding by the
Company was barred by this Agreement.

          7. Establishment of Trust. In the event of a Change in Control, the Company shall,
upon written request by Indemnitee, create a Trust for the benefit of the Indemnitee and from time
to time upon written request of Indemnitee shall fund the Trust in an amount sufficient to satisfy
any and all Expenses reasonably anticipated at the time of each such request to be incurred in
connection with investigating, preparing for, participating in, and/or defending any Proceeding
relating to an Indemnifiable Event. The amount or amounts to be deposited in the Trust pursuant to
the foregoing funding obligation shall be determined by the Independent Counsel. The terms of
the Trust shall provide that (i) the Trust shall not be revoked or the principal thereof invaded
without the written consent of the Indemnitee, (ii) the Trustee shall advance, within thirty (30)
days of a request by the Indemnitee, any and all Expenses to the Indemnitee (and the Indemnitee
hereby agrees to reimburse the Trust under the same circumstances for which the Indemnitee would be
required to reimburse the Company under Section 2(c) of this Agreement), (iii) the Trust shall
continue to be funded by the Company in accordance with the funding obligation set forth above,
(iv) the Trustee shall promptly pay to the Indemnitee all amounts for which the Indemnitee shall be
entitled to indemnification pursuant to this Agreement or otherwise no later than thirty (30) days
after notice pursuant to Section 4(a) and (v) all unexpended funds in the Trust shall revert to the
Company upon a final determination by the Independent Counsel or a court of competent jurisdiction,
as the case may be, that the Indemnitee has been fully indemnified under the terms of this
Agreement. The Trustee shall be chosen by the Indemnitee. Nothing in this Section 7 shall relieve
the Company of any of its obligations under this Agreement. All income earned on the assets held
in the Trust shall be reported as income by the Company for federal, state, local and foreign tax
purposes. The Company shall pay all costs of establishing and maintaining the Trust and shall
indemnify the Trustee against any and all expenses (including attorneys’ fees), claims,
liabilities, loss and damages arising out of or relating to this Agreement or the establishment and
maintenance of the Trust.

          8. Non-Exclusivity. The rights of Indemnitee hereunder shall be in addition to any
other rights Indemnitee may have under the Company’s Certificate of Incorporation, Bylaws,
applicable law or otherwise; provided, however, that this Agreement shall supersede any prior
indemnification agreement between the Company and the Indemnitee. To the extent that a change in
applicable law (whether by statute or judicial decision) permits greater indemnification than would
be afforded currently under the Company’s Certificate of Incorporation, Bylaws, applicable law or
this Agreement, it is the intent of the parties that Indemnitee enjoy by this Agreement the greater
benefits so afforded by such change.

          9. Liability Insurance. To the extent the Company maintains an insurance policy or
policies providing general and/or directors’ and officers’ liability insurance, Indemnitee shall be
covered by such policy or policies, in accordance with its or their terms, to the maximum extent of
the coverage available for any Company director or officer.

-8-

 

          10. Period of Limitations. No legal action shall be brought and no cause of action
shall be asserted by or on behalf of the Company or any Affiliate of the Company against
Indemnitee, Indemnitee’s spouse, heirs, executors or personal or legal representatives after the
expiration of two (2) years from the date of accrual of such cause of action or such longer period
as may be required by state law under the circumstances. Any claim or cause of action of the
Company or its Affiliate shall be extinguished and deemed released unless asserted by the timely
filing and notice of a legal action within such period; provided, however, that if any shorter
period of limitations is otherwise applicable to any such cause of action, the shorter period shall
govern.

          11. Amendment of this Agreement. No supplement, modification or amendment of this
Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of
any of the provisions of this Agreement shall be binding unless in the form of a writing signed by
the party against whom enforcement of the waiver is sought, and no such waiver shall
operate as a waiver of any other provisions hereof (whether or not similar), nor shall such
waiver constitute a continuing waiver. Except as specifically provided herein, no failure to
exercise or any delay in exercising any right or remedy hereunder shall constitute a waiver
thereof.

          12. Subrogation. In the event of payment under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall
execute all papers required and shall do everything that may be necessary to secure such rights,
including the execution of such documents necessary to enable the Company effectively to bring suit
to enforce such rights.

          13. No Duplication of Payments. The Company shall not be liable under this Agreement
to make any payment in connection with any claim made against Indemnitee to the extent Indemnitee
has otherwise received payment (under any insurance policy, Bylaw or otherwise) of the amounts
otherwise indemnifiable hereunder.

          14. Duration of Agreement. This Agreement shall continue until and terminate upon the
later of (a) ten (10) years after the date that Indemnitee shall have ceased to serve as a director
or officer of the Company or (b) one (1) year after the final termination of any Proceeding,
including any appeal, then pending in respect of which Indemnitee is granted rights of
indemnification or advancement of Expenses hereunder and of any proceeding commenced by Indemnitee
pursuant to Section 4(b) of this Agreement relating thereto.

          15. Binding Effect. This Agreement shall be binding upon and inure to the benefit of
and be enforceable by the parties hereto and their respective successors (including any direct or
indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of
the business and/or assets of the Company), assigns, spouses, heirs and personal and legal
representatives. The Company shall require and cause any successor (whether direct or indirect by
purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of
the business and/or assets of the Company, by written agreement in form and substance satisfactory
to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to
the same extent that the Company would be required to perform if no such succession had taken
place. The indemnification provided under this Agreement shall continue as to Indemnitee for any
action taken or not taken while serving in an indemnified capacity pertaining to an Indemnifiable
Event even though Indemnitee may have ceased to serve in such capacity at the time of any
Proceeding.

-9-

 

          16. Severability. If any provision (or portion thereof) of this Agreement shall be
held by a court of competent jurisdiction to be invalid, void or otherwise unenforceable, (a) the
remaining provisions shall remain enforceable to the fullest extent permitted by law; (b) such
provision or provisions shall be deemed reformed to the extent necessary to conform to applicable
law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest
extent possible, the provisions of this Agreement (including, without limitation, each portion of
this Agreement containing any provision held to be invalid, void or otherwise unenforceable, that
is not itself invalid, void or unenforceable) shall be construed so as to give effect to the intent
manifested by the provision held invalid, void or unenforceable.

          17. Contribution. To the fullest extent permissible under applicable law, whether or
not the indemnification provided for in this Agreement is available to Indemnitee for any reason
whatsoever, the Company shall pay all or a portion of the amount that would otherwise be incurred
by Indemnitee for Expenses in connection with any claim relating to an Indemnifiable Event, as is
deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to
reflect (i) the relative benefits received by the Company and Indemnitee as a result of the
event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of
the Company (and its directors, officers, employees and agents) and Indemnitee in connection with
such event(s) and/or transaction(s).

          18. Governing Law. This Agreement shall be governed by and construed and enforced in
accordance with the laws of the State of Delaware applicable to contracts made and to be performed
in such State without giving effect to its principles of conflicts of laws. The Company and
Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising
out of or in connection with this Agreement may be brought in the Delaware Court of Chancery, (ii)
consent to submit to the jurisdiction of the Delaware Court of Chancery for purposes of any action
or proceeding arising out of or in connection with this Agreement, (iii) waive any objection to the
laying of venue of any such action or proceeding in the Delaware Court of Chancery, and (iv) waive,
and agree not to plead or to make, any claim that any such action or proceeding brought in the
Delaware Court of Chancery has been brought in an improper or inconvenient forum.

          19. Notices. All notices, demands and other communications required or permitted
hereunder shall be made in writing and shall be deemed to have been duly given if delivered by
hand, against receipt or mailed, postage prepaid, certified or registered mail, return receipt
requested and addressed to the Company at:

Perlegen Sciences, Inc.

2021 Stierlin Court

Mountain View, CA 94043-4655

Attention: Chief Executive Officer

and to Indemnitee at:

the address set forth below Indemnitee’s signature hereto. Notice of change of address shall
be effective only when given in accordance with this Section. All notices complying with this
Section shall be deemed to have been received on the date of hand delivery or on the third business
day after mailing.

          20. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.

* * * * *

-10-

 

     IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement
as of the day specified above.

	 	 	 	 	 	 	 
	 	 	PERLEGEN SCIENCES, INC.	 	 
	 	 	a Delaware corporation	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 	 	Print Name:	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 	 	INDEMNITEE,	 	 
	 	 	an individual	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	Indemniteeexv10w2

 

Exhibit 10.2

PERLEGEN SCIENCES, INC.

2001 STOCK OPTION AND INCENTIVE PLAN

 

 

Table of Contents

	 	 	 	 	 	 	 
	 	 	 	 	Page
	
ARTICLE I

GENERAL
	 
	 	 	 	 	 	 
	1.1

	 	Purpose
	 	 	1	 
	1.2

	 	Definitions of Certain Terms
	 	 	1	 
	1.3

	 	Administration
	 	 	2	 
	1.4

	 	Persons Eligible for Awards
	 	 	3	 
	1.5

	 	Types of Awards Under Plan
	 	 	3	 
	1.6

	 	Shares Available for Awards
	 	 	3	 
	 
	 	 	 	 	 	 
	
ARTICLE II

AWARDS UNDER THE PLAN
	 
	 	 	 	 	 	 
	2.1

	 	Award Agreements
	 	 	4	 
	2.2

	 	No Rights as a Shareholder
	 	 	4	 
	2.3

	 	Grant of Stock Options, Stock Appreciation
	 	 	5	 
	2.4

	 	Exercise of Stock Options and Stock Appreciation Rights
	 	 	6	 
	2.5

	 	Termination of Employment
	 	 	7	 
	2.6

	 	Grant of Restricted Stock
	 	 	8	 
	2.7

	 	Grant of Restricted Stock Units
	 	 	9	 
	2.8

	 	Grant of Performance Shares and Share Units
	 	 	9	 
	2.9

	 	Other Stock-Based Awards
	 	 	10	 
	2.10

	 	Grant of Dividend Equivalent Rights
	 	 	10	 
	 
	 	 	 	 	 	 
	
ARTICLE III

MISCELLANEOUS
	 
	 	 	 	 	 	 
	3.1

	 	Amendment of the Plan; Modification of Awards
	 	 	10	 
	3.2

	 	Tax Withholding
	 	 	11	 
	3.3

	 	Restrictions
	 	 	11	 
	3.4

	 	Nonassignability
	 	 	12	 
	3.5

	 	Requirement of Notification of
Election Under Section 83(b) of the Code
	 	 	12	 
	3.6

	 	Requirement of Notification Upon Disqualifying
Disposition Under Section 421(b) of the Code
	 	 	12	 
	3.7

	 	Merger, Sale, or Liquidation of the Company
	 	 	12	 
	3.8

	 	No Right to Employment
	 	 	13	 
	3.9

	 	Nature of Payments
	 	 	14	 
	3.10

	 	Non-Uniform Determinations
	 	 	14	 
	3.11

	 	Other Payments or Awards
	 	 	14	 
	3.12

	 	Section Headings
	 	 	14	 
	3.13

	 	Effective Date and Term of Plan
	 	 	14	 
	3.14

	 	Governing Law
	 	 	14	 
	3.15

	 	Financial Reports
	 	 	15	 
	3.16

	 	Severability; Entire Agreement
	 	 	15	 
	3.17

	 	Waiver of Claims
	 	 	15	 
	3.18

	 	No Third Party Beneficiaries
	 	 	15	 
	3.19

	 	Successors and Assigns
	 	 	15	 

 

 

ARTICLE I

GENERAL

1.1 Purpose

          The purpose of the Perlegen Sciences, Inc. 2001 Stock Option and Incentive Plan (the
“Plan”) is to provide an incentive for officers, other employees, prospective employees and
directors of, and consultants to, Perlegen Sciences, Inc. (the “Company”) and its subsidiaries and
affiliates to acquire a proprietary interest in the success of the Company, to enhance the
long-term performance of the Company and to remain in the service of the Company and its
subsidiaries and affiliates.

1.2 Definitions of Certain Terms

	 	(a)	 	“Award” means an award under the Plan as described in
Section 1.5 and Article II.
	 
	 	(b)	 	“Award Agreement” means a written agreement entered
into between the Company and a Grantee in connection with an Award.
	 
	 	(c)	 	“Beneficial Owner” has the meaning ascribed to such
terms in Rule 13d-3 of the General Rules and Regulations under the Exchange
Act.
	 
	 	(d)	 	“Board” means the Board of Directors of the Company.
	 
	 	(e)	 	“Code” means the Internal Revenue Code of 1986, as amended.
	 
	 	(f)	 	“Committee” means the Compensation Committee of the
Board.
	 
	 	(g)	 	“Common Stock” means the common stock, par value
$0.0001 per share, of the Company.
	 
	 	(h)	 	“Employment” means the Grantee being an employee of the
Company or a Related Entity, or in the case of a Grantee who is not an employee
of the Company or a Related Entity, the Grantee’s association with the Company
or a Related Entity as a director, consultant or otherwise.
	 
	 	(i)	 	“Exchange Act” means the Securities Exchange Act of
1934, as amended.
	 
	 	(j)	 	The “Fair Market Value” of a share of Common Stock on
any date shall be (i) the closing sale price per share of Common Stock during
normal trading hours on the national securities exchange on which the Common
Stock is principally traded for such date or the last preceding date on which
there was a sale of such Common Stock on such exchange or (ii) if the shares of
Common Stock are then traded in an over-the-counter market, the average of the
closing bid and asked prices for the shares of Common Stock during normal
trading hours in such over-the-counter market for such date or the last
preceding date on which there was a sale of such Common Stock in such market,
or (iii) if the shares of Common Stock are not then listed on a national
securities exchange or traded in an over-the-counter market, such value as the
Committee, in its sole discretion, shall determine.
	 
	 	(k)	 	“Grantee” means a person who receives an Award.

1

 

	 	(l)	 	“Incentive Stock Option” means a stock option that is
intended to qualify for special federal income tax treatment pursuant to
Sections 421 and 422 of the Code (or a successor provision thereof) and which
is so designated in the applicable Award Agreement. Under no circumstances
shall any stock option that is not specifically designated as an Incentive
Stock Option be considered an Incentive Stock Option.
	 
	 	(m)	 	“Key Persons” means directors, officers and other
employees of the Company or of a Related Entity, and consultants to the Company
or a Related Entity.
	 
	 	(n)	 	“Option Exercise Price” means the amount payable by a
Grantee on the exercise of a stock option.
	 
	 	(o)	 	“Related Entity” means any parent or subsidiary
corporation of the Company or any business, corporation, partnership, limited
liability company or other entity in which the Company or a parent or a
subsidiary corporation holds a controlling ownership interest, directly or
indirectly.
	 
	 	(p)	 	“Rule 16b-3” means Rule 16b-3 under the Exchange Act.
	 
	 	(q)	 	Unless otherwise determined by the Committee, a Grantee shall
be deemed to have a “Termination of Employment” upon ceasing employment
and association as a Key Person with the Company and all Related Entities. The
Committee in its discretion may determine (a) whether any leave of absence
constitutes a Termination of Employment for purposes of the Plan, (b) the
impact, if any, of any such leave of absence on Awards theretofore made under
the Plan, and (c) when a change in a Grantee’s association with the Company or
a Related Entity constitutes a Termination of Employment for purposes of the
Plan. The Committee may also determine whether a Grantee’s Termination of
Employment is for cause and the date of termination in such case.

1.3 Administration

              (a) The Plan shall be administered by the Committee, which shall consist of not less than two
directors. Except as otherwise determined by the Board, the members of the Committee shall be
“non-employee directors” under Rule 16b-3, and “outside directors” under Section 162(m) of the
Code. The Committee may delegate any of its powers under the Plan to a subcommittee of the
Committee consisting of non-employee directors and outside directors.

              (b) The Committee or a subcommittee thereof (which hereinafter shall also be referred to as
the Committee) shall have full discretion and authority (i) to exercise all of the powers granted
to it under the Plan, (ii) to construe, interpret and implement the Plan and any Award Agreements,
(iii) to prescribe, amend and rescind rules and regulations relating to the Plan, including rules
governing its own operations, (iv) to make all determinations necessary or advisable in
administering the Plan, (v) to correct any defect, supply any omission and reconcile any
inconsistency in the Plan, (vi) to amend the Plan to reflect changes in applicable law, (vii) to
determine whether, to what extent and under what circumstances Awards may be settled or exercised
in cash, shares of Common Stock, other securities, other Awards or other property, or canceled,
forfeited or suspended and the method or methods by which Awards may be settled,

2

 

canceled, forfeited or suspended, (viii) to determine whether, to what extent and under what
circumstances cash, shares of Common Stock, other securities, other Awards or other property and
other amounts payable with respect to an Award shall be deferred either automatically or at the
election of the holder thereof or of the Committee and (ix) to delegate administrative duties to
employees of the Company.

             (c) Actions of the Committee shall be taken by the vote of a majority of its members. Any
action may be taken by a written instrument signed by a majority of the Committee members, and
action so taken shall be fully as effective as if it had been taken by a vote at a meeting.

             (d) The determination of the Committee on all matters relating to the Plan or any Award
Agreement shall be final, binding and conclusive.

             (e) No member of the Committee shall be liable for any action or determination made in good
faith with respect to the Plan or any Award.

             (f) Notwithstanding anything to the contrary contained herein: (a) until the Board shall
appoint the members of the Committee, the Plan shall be administered by the Board and (b) the Board
may, in its sole discretion, at any time and from time to time, grant Awards or resolve to
administer the Plan. In either of the foregoing events, the Board shall have all of the authority
and responsibility granted to the Committee herein.

1.4 Persons Eligible for Awards

          Awards under the Plan may be made to such Key Persons as the Committee shall select in its
discretion.

1.5 Types of Awards Under Plan

          Awards may be made under the Plan in the form of stock options, including Incentive Stock
Options, stock appreciation rights, restricted stock, restricted stock units, performance shares
and share units and other stock-based Awards, as set forth in Article II.

1.6 Shares Available for Awards

             (a) Total
shares available. The total number of shares of Common Stock, which may be transferred pursuant to Awards granted under the Plan shall not exceed 10,200,000 shares. Such
shares may be authorized but unissued Common Stock or authorized and issued Common Stock held in
the Company’s treasury or acquired by the Company for the purposes of the Plan. The Committee may
direct that any stock certificate evidencing shares issued pursuant to the Plan shall bear a legend
setting forth such restrictions on transferability as may apply to such shares pursuant to the
Plan. If any Award is forfeited or otherwise terminates or is canceled without the delivery of
shares of Common Stock, shares of Common Stock are surrendered or withheld from any Award to
satisfy a Grantee’s income tax withholding obligations, or shares of Common Stock owned by a
Grantee are tendered to pay the exercise price of options granted under the Plan, then the shares
covered by such forfeited, terminated or canceled Award or which are equal to the number of shares
surrendered, withheld or tendered shall again become available for transfer pursuant to Awards
granted or to be granted under this Plan. Any shares of Common Stock delivered by the Company, any
shares of Common Stock with respect to which Awards are made by the Company and any shares of
Common Stock with respect to which the Company becomes obligated to make Awards, through the
assumption of, or in substitution for,
outstanding awards previously granted by an acquired entity, shall not be counted against the
shares available for Awards under this Plan.

3

 

             (b) Adjustments. The number of shares of Common Stock covered by each outstanding
Award, the number of shares available for Awards, the number of shares that may be subject to
Awards to any one Grantee, and the price per share of Common Stock covered by each such outstanding
Award may be proportionately adjusted, as determined in the sole discretion of the Committee, for
any increase or decrease in the number of issued shares of Common Stock resulting from a stock
split, reverse stock split, stock dividend, recapitalization, combination or reclassification of
the Common Stock, or any other increase or decrease in the number of issued shares of Common Stock
effected without receipt of consideration by the Company or to reflect any distributions to holders
of Common Stock other than regular cash dividends; provided, however, that
conversion of any convertible securities of the Company shall not be deemed to have been “effected
without receipt of consideration.” Except as expressly provided herein, no issuance by the Company
of shares of stock of any class, or securities convertible into shares of stock of any class, shall
affect, and no adjustment by reason thereof shall be made with respect to, the number or price of
shares of Common Stock subject to an Award. After any adjustment made pursuant to this paragraph,
the number of shares subject to each outstanding Award shall be rounded to the nearest whole
number.

ARTICLE II

AWARDS UNDER THE PLAN

2.1 Award Agreements

          Each Award granted under the Plan shall be evidenced by an Award Agreement which shall contain
such provisions as the Committee in its discretion deems necessary or desirable. Such provisions
may include, without limitation, a requirement that the Grantee become a party to a shareholders’
agreement with respect to any shares of Common Stock acquired pursuant to the Award, a requirement
that the Grantee acknowledge that such shares are acquired for investment purposes only, and a
right of first refusal exercisable by the Company in the event that the Grantee wishes to transfer
any such shares. The Committee may grant Awards in tandem with or in substitution for any other
Award or Awards granted under this Plan or in connection with satisfaction of any award granted
under any other plan of the Company. Payments or transfers to be made by the Company upon the
grant, exercise or payment of an Award may be made in such form as the Committee shall determine,
including cash, shares of Common Stock, other securities, other Awards or other property and may be
made in a single payment or transfer, in installments or on a deferred basis. A Grantee shall have
no rights with respect to an Award unless such Grantee accepts the Award within such period as the
Committee shall specify by executing an Award Agreement in such form as the Committee shall
determine and, if the Committee shall so require, makes payment to the Company in such amount as
the Committee may determine. The Committee shall determine if loans (whether or not secured by
shares of Common Stock) may be extended or guaranteed by the Company with respect to any Awards.

2.2 No Rights as a Shareholder

          No Grantee of an Award (or other person having rights pursuant to such Award) shall have any
of the rights of a shareholder of the Company with respect to shares subject to such Award until
the issuance of a stock certificate to such person for such shares. Except as
otherwise provided in Section 1.6(b), no adjustment shall be made for dividends, distributions or
other rights (whether ordinary or extraordinary, and whether in cash, securities or other property)
for which the record date is prior to the date such stock certificate is issued.

4

 

2.3 Grant of Stock Options, Stock Appreciation Rights and Additional Options

          (a) The Committee may grant stock options, including Incentive Stock Options to purchase
shares of Common Stock from the Company, to such Key Persons, in such amounts and subject to such
terms and conditions, as the Committee shall determine in its discretion.

          (b) The Committee may grant stock appreciation rights to such Key Persons, in such amounts and
subject to such terms and conditions, as the Committee shall determine in its discretion. Stock
appreciation rights may be granted in connection with all or any part of, or independently of, any
stock option granted under the Plan. A stock appreciation right may be granted at or after the
time of grant of such option.

          (c) The Grantee of a stock appreciation right shall have the right, subject to the terms of
the Plan and the applicable Award Agreement, to receive from the Company an amount equal to (i) the
excess of the Fair Market Value of a share of Common Stock on the date of exercise of the stock
appreciation right over (ii) the exercise price of such right as set forth in the Award Agreement
(or over the option exercise price if the stock appreciation right is granted in connection with a
stock option), multiplied by (iii) the number of shares with respect to which the stock
appreciation right is exercised. Payment to the Grantee upon exercise of a stock appreciation
right shall be made in cash or in shares of Common Stock (valued at their Fair Market Value on the
date of exercise of the stock appreciation right) or both, as the Committee shall determine in its
discretion. Upon the exercise of a stock appreciation right granted in connection with a stock
option, the number of shares subject to the option shall be correspondingly reduced by the number
of shares with respect to which the stock appreciation right is exercised. Upon the exercise of a
stock option in connection with which a stock appreciation right has been granted, the number of
shares subject to the stock appreciation right shall be correspondingly reduced by the number of
shares with respect to which the option is exercised.

          (d) Each Award Agreement with respect to a stock option shall set forth the Option Exercise
Price, which shall be determined by the Committee in its discretion; provided,
however, with respect to an option granted prior to the time at which the requirements of
Section 25100(o) of the California Corporations Code, to the extent applicable and as modified from
time to time (relating to securities listed on a national exchange) are satisfied, the Option
Exercise Price per share shall not be less than 85% of the Fair Market Value of a share of Common
Stock on the date the option is granted, except that the option exercise price per share for grants
to individuals who own more than 10% of the total voting power of all classes of outstanding Common
Stock of the Company, its parent or any of its subsidiaries shall not be less than 110% of the Fair
Market Value of a share of Common Stock on the date the option is granted.

          (e) Each Award Agreement with respect to a stock option or stock appreciation right shall set
forth the periods during which the Award evidenced thereby shall be exercisable, whether in whole
or in part. Such periods shall be determined by the Committee in

5

 

its discretion; provided, however, that no Incentive Stock Option (or a stock
appreciation right granted in connection with an Incentive Stock Option) shall be exercisable more
than 10 years after the date of grant. In addition, with respect to a stock option or stock
appreciation right granted prior to the time at which the requirements of Section 25100(o) of the
California Corporations Code, to the extent applicable and as modified from time to time (relating
to securities listed on a national exchange) are satisfied, no such option or stock appreciation
right shall have a term in excess of 120 months from the date of grant.

          (f) The Committee in its discretion may include in any Award Agreement with respect to a stock
option (the “original option”) a provision that an additional stock option (the
“additional option”) shall be granted to any Grantee who, pursuant to Section 2.4(c),
delivers shares of Common Stock in partial or full payment of the exercise price of the original
option. The additional option shall be for a number of shares of Common Stock equal to the number
thus delivered, shall have an Option Exercise Price equal to the Fair Market Value of a share of
Common Stock on the date of exercise of the original option, and shall have an expiration date no
later than the expiration date of the original option. In the event that an Award Agreement
provides for the grant of an additional option, such Agreement shall also provide that the exercise
price of the original option be no less than the Fair Market Value of a share of Common Stock on
its date of grant, and that any shares that are delivered pursuant to Section 2.4(c) in payment of
such exercise price shall have been held by the Grantee for at least six months.

          (g) To the extent that the aggregate Fair Market Value (determined as of the time the option
is granted) of the stock with respect to which Incentive Stock Options granted under this Plan and
all other plans of the Company are first exercisable by any Grantee during any calendar year shall
exceed the maximum limit (currently, $100,000), if any, imposed from time to time under Section 422
of the Code, such options shall be treated as nonqualified stock options.

          (h) Notwithstanding the provisions of Sections 2.3(d) and (e), to the extent required under
Section 422 of the Code, an Incentive Stock Option may not be granted under the Plan to an
individual who, at the time the option is granted, owns stock possessing more than 10% of the total
combined voting power of all classes of stock of his or her employer corporation or of its parent
or subsidiary corporations (as such ownership may be determined for purposes of Section 422(b)(6)
of the Code) unless (i) at the time such Incentive Stock Option is granted the Option Exercise
Price is at least 110% of the Fair Market Value of the shares subject thereto and (ii) the
Incentive Stock Option by its terms is not exercisable after the expiration of five (5) years from
the date granted.

2.4 Exercise of Stock Options and Stock Appreciation Rights

          Each stock option or stock appreciation right granted under the Plan shall be exercisable as
follows:

          (a) A stock option or stock appreciation right shall become exercisable at such time or times
as determined by the Committee; provided, however, that any option or stock
appreciation right granted prior to the time at which the requirements of Section 25100(o) of the
California Corporations Code, to the extent applicable and as modified from time to time (relating
to securities listed on a national exchange), are satisfied, in the case a Grantee who is not an
officer of the Company, an outside director of the Company or a consultant to the
Company, shall become exercisable at least as rapidly as 20% per year over the five-year
period commencing on the date of grant.

6

 

          (b) Unless the applicable Award Agreement otherwise provides, a stock option or stock
appreciation right may be exercised from time to time as to all or part of the shares as to which
such Award is then exercisable (but, in any event, only for whole shares). A stock appreciation
right granted in connection with an option may be exercised at any time when, and to the same
extent that, the related option may be exercised. A stock option or stock appreciation right shall
be exercised by written notice to the Company, on such form and in such manner as the Committee
shall prescribe.

          (c) Any written notice of exercise of a stock option shall be accompanied by payment of the
Option Exercise Price for the shares being purchased. Such payment shall be made (i) in cash (by
certified check or as otherwise permitted by the Committee), or (ii) to the extent specified in the
Award Agreement (A) by delivery of shares of Common Stock (which, if acquired pursuant to the
exercise of a stock option or under an Award made under this Plan or any other compensatory plan of
the Company, were acquired at least six (6) months prior to the option exercise date) having a Fair
Market Value (determined as of the exercise date) equal to all or part of the Option Exercise Price
and cash for any remaining portion of the Option Exercise Price, or (B) to the extent permitted by
law, by such other method as the Committee may from time to time prescribe, including a cashless
exercise procedure through a broker-dealer.

          (d) Promptly after receiving payment of the full Option Exercise Price, or after receiving
notice of the exercise of a stock appreciation right for which payment will be made partly or
entirely in shares of Common Stock, the Company shall, subject to the provisions of Section 3.3
(relating to certain restrictions), deliver to the Grantee or to such other person as may then have
the right to exercise the Award, a certificate or certificates for the shares of Common Stock for
which the Award has been exercised. If the method of payment employed upon option exercise so
requires, and if applicable law permits, a Grantee may direct the Company to deliver the
certificate(s) to the Grantee’s broker-dealer.

2.5 Termination of Employment

          (a) Except to the extent otherwise provided in paragraphs (b) and (c) below or in the
applicable Award Agreement, all stock options and stock appreciation rights not theretofore
exercised shall terminate upon the Grantee’s Termination of Employment for any reason.

          (b) Upon the Termination of Employment of the Grantee for any reason other than death or
dismissal for cause, the Grantee may exercise any outstanding stock option or stock appreciation
right on the following terms and conditions, unless otherwise provided in the Award Agreement: (i)
exercise may be made only to the extent that the Grantee was entitled to exercise the Award on the
date of the Termination of Employment; and (ii) exercise must occur within ninety (90) day after
the Termination of Employment, except that this ninety (90) day period shall be increased to one
year if the termination is by reason of disability, but in no event after the expiration date of
the Award as set forth in the Award Agreement. In the case of an Incentive Stock Option, the term
“disability” for purposes of the preceding sentence shall have the meaning given to it by
Section 422(c)(6) of the Code.

7

 

          (c) If a Grantee dies while employed by the Company or a Related Entity, or after a
Termination of Employment but during the period in which the Grantee’s Awards are exercisable
pursuant to paragraph (b) above, any outstanding stock option or stock appreciation right shall be
exercisable on the following terms and conditions: (i) exercise may be made only to the extent
that the Grantee was entitled to exercise the Award on the date of death and (ii) exercise must
occur by the earlier of the first anniversary of the Grantee’s death or the expiration date of the
Award. Any such exercise of an Award following a Grantee’s death shall be made only by the
Grantee’s executor or administrator, unless the Grantee’s will specifically disposes of such Award,
in which case such exercise shall be made only by the recipient of such specific disposition. If a
Grantee’s personal representative or the recipient of a specific disposition under the Grantee’s
will shall be entitled to exercise any Award pursuant to the preceding sentence, such
representative or recipient shall be bound by all the terms and conditions of the Plan and the
applicable Award Agreement which would have applied to the Grantee.

          (d) Notwithstanding the above paragraphs of this Section, the following time limits shall be
provided, at a minimum, with respect to stock options and stock appreciation rights granted prior
to the time at which the requirements of Section 25100(o) of the California Corporations Code, to
the extent applicable and as modified from time to time (relating to securities listed on a
national exchange) are satisfied: (i) with respect to clause (ii) of paragraph (b) of this
Section, an exercise period of at least 30 days from the date of the Termination of Employment or 6
months if the termination is by reason of disability and (ii) with respect to clause (ii) of
paragraph (c) of this Section, an exercise period of at least 6 months from the date of the
Termination of Employment, but in either event no later than the expiration date of the Award.

2.6 Grant of Restricted Stock

          (a) The Committee may grant restricted shares of Common Stock to such Key Persons, in such
amounts, and subject to such terms and conditions as the Committee shall determine in its
discretion, subject to the provisions of the Plan. Restricted stock Awards may be made
independently of or in connection with any other Award.

          (b) The Company shall issue in the Grantee’s name a certificate or certificates for the shares
of Common Stock covered by the Award. Upon the issuance of such certificate(s), the Grantee shall
have the rights of a shareholder with respect to the restricted stock, subject to the transfer
restrictions and the Company repurchase rights described in paragraphs (d) and (e) below and to
such other restrictions and conditions as the Committee in its discretion may include in the
applicable Award Agreement.

          (c) Unless the Committee shall otherwise determine, any certificate issued evidencing shares
of restricted stock shall remain in the possession of the Company until such shares are free of any
restrictions specified in the applicable Award Agreement.

          (d) Shares of restricted stock may not be sold, assigned, transferred, pledged or otherwise
encumbered or disposed of except as specifically provided in this Plan or the applicable Award
Agreement. The Committee at the time of grant shall specify the date or dates (which may depend
upon or be related to the attainment of performance goals and other conditions) on which the
nontransferability of the restricted stock shall lapse. Unless the applicable Award Agreement
provides otherwise, additional shares of Common Stock or other property distributed to the Grantee
in respect of shares of restricted stock, as dividends or

8

 

otherwise, shall be subject to the same restrictions applicable to such restricted stock. With
respect to restricted stock granted prior to the time at which the requirements of Section 25100(o)
of the California Corporations Code, to the extent applicable and as modified from time to time
(relating to securities listed on a national exchange), are satisfied, in the case of a Grantee who
is not an officer of the Company, an outside director of the Company or a consultant to the
Company, the nontransferability of the restricted stock shall lapse at least as rapidly as 20% per
year over the five-year period commencing on the date of grant.

          (e) During the 90 days following the Grantee’s Termination of Employment for any reason, the
Company shall have the right to require the return of any shares to which restrictions on
transferability apply, in exchange for which the Company shall repay to the Grantee (or the
Grantee’s estate) in cash any amount paid by the Grantee for such shares.

2.7 Grant of Restricted Stock Units

          (a) The Committee may grant Awards of restricted stock units to such Key Persons, in such
amounts, and subject to such terms and conditions as the Committee shall determine in its
discretion, subject to the provisions of the Plan. Restricted stock units may be awarded
independently of or in connection with any other Award under the Plan.

          (b) At the time of grant, the Committee shall specify the date or dates on which the
restricted stock units shall become vested, and may specify such conditions to vesting as it deems
appropriate. Unless otherwise determined by the Committee, in the event of the Grantee’s
Termination of Employment for any reason, restricted stock units that have not vested shall be
forfeited and canceled. The Committee at any time may accelerate vesting dates and otherwise waive
or amend any conditions of an Award of restricted stock units. With respect to restricted stock
units granted prior to the time at which the requirements of Section 25100(o) of the California
Corporations Code, to the extent applicable and as modified from time to time (relating to
securities listed on a national exchange), are satisfied, in the case of a Grantee who is not an
officer of the Company, an outside director of the Company or a consultant to the Company, the
restricted stock units shall vest at least as rapidly as 20% per year over the five-year period
commencing on the date of grant.

          (c) At the time of grant, the Committee shall specify the maturity date applicable to each
grant of restricted stock units, which may be determined at the election of the Grantee. Such date
may be later than the vesting date or dates of the Award. On the maturity date, the Company shall
transfer to the Grantee one unrestricted, fully transferable share of Common Stock for each vested
restricted stock unit scheduled to be paid out on such date and as to which all other conditions to
the transfer have been fully satisfied. The Committee shall specify the purchase price, if any, to
be paid by the Grantee to the Company for such shares of Common Stock.

2.8 Grant of Performance Shares and Share Units

          The Committee may grant performance shares in the form of actual shares of Common Stock or
share units having a value equal to an identical number of shares of Common Stock to such Key
Persons, in such amounts, and subject to such terms and conditions as the Committee shall determine
in its discretion, subject to the provisions of the Plan. In the event that a stock certificate is
issued in respect of performance shares, such certificates shall be registered in the name of the
Grantee but shall be held by the Company until the time the

9

 

performance shares are earned. The performance conditions and the length of the performance period
shall be determined by the Committee. The Committee shall determine in its sole discretion whether
performance shares granted in the form of share units shall be paid in cash, Common Stock, or a
combination of cash and Common Stock.

2.9 Other Stock-Based Awards

          The Committee may grant other types of stock-based Awards to such Key Persons, in such amounts
and subject to such terms and conditions, as the Committee shall in its discretion determine,
subject to the provisions of the Plan. Such Awards may entail the transfer of actual shares of
Common Stock, or payment in cash or otherwise of amounts based on the value of shares of Common
Stock.

2.10 Grant of Dividend Equivalent Rights

          The Committee may in its discretion include in the Award Agreement with respect to any Award a
dividend equivalent right entitling the Grantee to receive amounts equal to the ordinary dividends
that would be paid, during the time such Award is outstanding and unexercised, on the shares of
Common Stock covered by such Award if such shares were then outstanding. In the event such a
provision is included in an Award Agreement, the Committee shall determine whether such payments
shall be made in cash, in shares of Common Stock or in another form, whether they shall be
conditioned upon the exercise of the Award to which they relate, the time or times at which they
shall be made, and such other terms and conditions as the Committee shall deem appropriate.

ARTICLE III

MISCELLANEOUS

3.1 Amendment of the Plan; Modification of Awards

          (a) The Board may from time to time suspend, discontinue, revise or amend the Plan in any
respect whatsoever, except that no such amendment shall materially impair any rights or materially
increase any obligations of the Grantee under any Award theretofore made under the Plan without the
consent of the Grantee (or, after the Grantee’s death, the person having the right to exercise or
receive payment of the Award). For purposes of the Plan, any action of the Board or the Committee
that alters or affects the tax treatment of any Award shall not be considered to materially impair
any rights of any Grantee.

          (b) Shareholder approval of any amendment shall be obtained to the extent necessary to comply
with Section 422 of the Code (relating to Incentive Stock Options) or any other applicable law or
regulation.

          (c) The Committee may amend any outstanding Award Agreement, including, without limitation, by
amendment which would accelerate the time or times at which the Award becomes unrestricted or may
be exercised, or waive or amend any goals, restrictions or conditions set forth in the Award
Agreement. However, any such amendment (other than an amendment pursuant to paragraphs (a) or (d)
of this Section or an assumption pursuant to Section 3.7(b)) that materially impairs the rights or
materially increases the obligations of a Grantee under an outstanding Award shall be made only
with the consent of the Grantee (or, upon the Grantee’s death, the person having the right to
exercise the Award).

10

 

          (d) Notwithstanding anything to the contrary in this Section, the Board or the Committee shall
have full discretion to amend the Plan to the extent necessary to permit the Company to utilize the
pooling-of-interests accounting method or to preserve fixed accounting treatment with respect to
any Award pursuant to APB 25, as revised from time to time, and any outstanding Award Agreement
shall be deemed to be so amended to the same extent, without obtaining the consent of any Grantee
(or, after the Grantee’s death, the person having the right to exercise or receive payment of the
affected Award), without regard to whether such amendment adversely affects a Grantee’s rights
under the Plan or such Award Agreement.

3.2 Tax Withholding

          (a) As a condition to the receipt of any shares of Common Stock pursuant to any Award or the
lifting of restrictions on any Award, or in connection with any other event that gives rise to a
federal or other governmental tax withholding obligation on the part of the Company relating to an
Award (including, without limitation, FICA tax), the Company shall be entitled to require that the
Grantee remit to the Company an amount sufficient in the opinion of the Company to satisfy such
withholding obligation.

          (b) If the event giving rise to the withholding obligation is a transfer of shares of Common
Stock, then, to the extent specified in the applicable Award Agreement and unless otherwise
permitted by the Committee, the Grantee may satisfy only the minimum statutory withholding
obligation imposed under paragraph (a) by electing to have the Company withhold shares of Common
Stock having a Fair Market Value equal to the amount of tax to be withheld. For this purpose, Fair
Market Value shall be determined as of the date on which the amount of tax to be withheld is
determined (and any fractional share amount shall be settled in cash).

3.3 Restrictions

          (a) If the Committee shall at any time determine that any consent (as hereinafter defined) is
necessary or desirable as a condition of, or in connection with, the granting of any Award, the
issuance or purchase of shares of Common Stock or other rights thereunder, or the taking of any
other action thereunder (a “Plan Action”), then no such Plan Action shall be taken, in whole or in
part, unless and until such consent shall have been effected or obtained to the full satisfaction
of the Committee.

          (b) The term “consent” as used herein with respect to any action referred to in
paragraph (a) means (i) any and all listings, registrations or qualifications in respect thereof
upon any securities exchange or under any federal, state or local law, rule or regulation, (ii) any
and all written agreements and representations by the Grantee with respect to the disposition of
shares, or with respect to any other matter, which the Committee shall deem necessary or desirable
to comply with the terms of any such listing, registration or qualification or to obtain an
exemption from the requirement that any such listing, qualification or registration be made, (iii)
any and all consents, clearances and approvals in respect of a Plan Action by any governmental or
other regulatory bodies, and (iv) any and all consents or authorizations required to comply with,
or required to be obtained under, applicable local law or otherwise required by the Committee.
Nothing herein shall require the Company to list, register or qualify the shares of Common Stock on
any securities exchange.

11

 

3.4 Nonassignability

          Except to the extent otherwise provided in the applicable Award Agreement, no Award or right
granted to any person under the Plan shall be assignable or transferable other than by will or by
the laws of descent and distribution, and all such Awards and rights shall be exercisable during
the life of the Grantee only by the Grantee or the Grantee’s legal representative. Notwithstanding
the immediately preceding sentence, the Committee may permit a Grantee to transfer any stock option
which is not an Incentive Stock Option to one or more of the Grantee’s immediate family members or
to trusts established in whole or in part for the benefit of the Grantee and/or one or more of such
immediate family members. For purposes of the Plan, (i) the term “immediate family” shall
mean the Grantee’s spouse and issue (including adopted and step children) and (ii) the phrase
“immediate family members or to trusts established in whole or in part for the benefit of the
Grantee and/or one or more of such immediate family members” shall be further limited, if
necessary, so that neither the transfer of a nonqualified stock option to such immediate family
member or trust, nor the ability of a Grantee to make such a transfer shall have adverse
consequences to the Company or the Grantee by reason of Section 162(m) of the Code.

3.5 Requirement of Notification of Election Under Section 83(b) of the Code

     If a Grantee, in connection with the acquisition of shares of Common Stock under the Plan, is
permitted under the terms of the Award Agreement to make the election permitted under Section 83(b)
of the Code (i.e., an election to include in gross income in the year of transfer the amounts
specified in Section 83(b) of the Code notwithstanding the continuing transfer restrictions) and
the Grantee makes such an election, the Grantee shall notify the Company of such election within
ten (10) days of filing notice of the election with the Internal Revenue Service, in addition to
any filing and notification required pursuant to regulations issued under Section 83(b) of the
Code.

3.6  Requirement of Notification Upon Disqualifying Disposition Under Section 421(b) of the Code

          If any Grantee shall make any disposition of shares of Common Stock issued pursuant to the
exercise of an Incentive Stock Option under the circumstances described in Section 421(b) of the
Code (relating to certain disqualifying dispositions), such Grantee shall notify the Company of
such disposition within ten (10) days thereof.

3.7 Merger, Sale, or Liquidation of the Company

          (a) In the event of (i) a merger or consolidation (“merger”) of the Company with or
into any other corporation or entity, (ii) a sale of all or substantially all of the Company’s
assets (“sale”) to any other corporation or entity or (iii) any transaction by which another
person, corporation or entity (other than Affymetrix, Inc. (“Affymetrix”) and any corporation or
entity in which Affymetrix holds a controlling interest, directly or indirectly) becomes the
Beneficial Owner of more than 50% of the issued and outstanding shares of capital stock of the
Company (in each case, such other corporation or acquiring entity being referred to as the
“successor corporation”), outstanding Awards shall, at the option of the successor corporation,
either (1) be assumed or an equivalent award shall be substituted by such successor corporation or
a parent or subsidiary of such successor corporation or (2) if not so assumed or substituted,
immediately vest

12

 

(including treating any performance conditions as being met) and be cashed out by the Company
based upon the Fair Market Value of the shares of Common Stock, the exercise price, if any, of any
Awards and the number of shares of Common Stock subject to the Awards. If outstanding Awards are
assumed or substituted as provided in (a)(1) above and shareholders of the Company immediately
before the merger or sale do not own more than 55% of the shares of successor corporation (unless
such successor corporation is Affymetrix or a corporation or entity in which holds a controlling
interest, directly or indirectly) stock that vote in the election of its directors after the merger
or sale (a “Qualifying Transaction”), each Grantee shall be credited with an additional 12 months
of service for vesting purposes (including treating any performance conditions in effect for such
12 month period as being met). For the purposes of this paragraph: an Award that has an exercise
price shall be considered assumed or substituted pursuant to clause (1) if in the reasonable
determination of the Committee (x) the aggregate intrinsic value (the difference between the fair
market value and the exercise price per share of common stock) of the assumed or substituted award
immediately after the merger or sale is substantially the same as the aggregate intrinsic value of
such Award immediately before such transaction and (y) the ratio of the exercise price per assumed
or substituted award to the fair market value per share of successor corporation stock immediately
after the merger or sale is substantially the same as the ratio on such Award immediately before
such merger or sale; and an Award that does not have an exercise price shall be considered assumed
if in the reasonable determination of the Committee the fair market value of the aggregate shares
underlying the assumed or substituted award immediately after the merger or sale is substantially
the same as the fair market value of the aggregate shares of Common Stock underlying the Award
immediately before such merger or sale.

          (b) In the event of a Qualifying Transaction where the successor corporation assumes or
substitutes for any outstanding Awards as provided in (a)(1) above, if within 18 months of the
consummation of such merger or sale the Grantee’s employment with the successor corporation is
terminated by the successor corporation other than for cause or the Grantee terminates employment
with the successor corporation for good reason, then all outstanding Awards owned by such
Participant shall immediately vest (including treating any performance conditions as being met) and
be cashed out by the successor corporation as described in (a)(2) above and any right of recapture
provided in such Grantee’s Award Agreement shall not be applicable. For purposes hereof, the term
“cause” shall have the meaning specified in the Grantee’s Award agreement or as otherwise
determined by the Committee in its discretion, and the term “good reason” shall have the meaning
specified in the Grantee’s Award agreement or as otherwise determined by the Committee in its
discretion.

          (c) In the event of a liquidation or dissolution of the Company, all of each Grantee’s
outstanding Awards shall immediately vest (including treating any performance conditions as being
met) and be cashed out by the Company as described in (a)(2) above.

3.8 No Right to Employment

          Nothing in the Plan or in any Award Agreement shall confer upon any Grantee the right to
continue in the employ of the Company or affect any right which the Company may have to terminate
such employment at any time (with or without cause).

13

 

3.9 Nature of Payments

          Any and all grants of Awards and issuances of shares of Common Stock under the Plan shall
constitute a special incentive payment to the Grantee and shall not be taken into account in
computing the amount of salary or compensation of the Grantee for the purpose of determining any
benefits under any pension, retirement, profit-sharing, bonus, life insurance or other benefit plan
of the Company or under any agreement with the Grantee, unless such plan or agreement specifically
provides otherwise.

3.10 Non-Uniform Determinations

          The Committee’s determinations under the Plan need not be uniform and may be made by it
selectively among persons who receive, or are eligible to receive, Awards (whether or not such
persons are similarly situated). Without limiting the generality of the foregoing, the Committee
shall be entitled, among other things, to make non-uniform and selective determinations, and to
enter into non-uniform and selective Award Agreements, as to the persons to receive Awards under
the Plan, and the terms and provisions of Awards under the Plan.

3.11 Other Payments or Awards

          Nothing contained in the Plan shall be deemed in any way to limit or restrict the Company from
making any Award or payment to any person under any other plan, arrangement or understanding,
whether now existing or hereafter in effect.

3.12 Section Headings

          The section headings contained herein are for the purpose of convenience only and are not
intended to define or limit the contents of the sections.

3.13 Effective Date and Term of Plan

          (a) Unless otherwise determined by the Board, all Awards under the Plan prior to shareholder
approval are subject in their entirety to such approval. If such approval is not obtained prior to
the first anniversary of the date of adoption of the Plan, the Plan and all Awards thereunder shall
terminate on that date.

          (b) Unless sooner terminated by the Board, the provisions of the Plan respecting the grant of
Incentive Stock Options shall terminate the day before the tenth anniversary of the adoption of the
Plan by the Board. All Awards made under the Plan prior to its termination shall remain in effect
until such Awards have been satisfied or terminated in accordance with the terms and provisions of
the Plan and the applicable Award Agreements.

          (c) If on the tenth anniversary of the date the Plan is adopted by the Board, the requirements
set forth in Section 25100(o) of the California Corporations Code, to the extent applicable and as
modified from time to time (relating to securities listed on a national exchange), have not been or
are not satisfied, then the Plan shall terminate. All Awards made under the Plan prior to its
termination under this Section 3.13(c) shall remain in effect until such Awards have been satisfied
or terminated in accordance with the terms and provisions of the Plan and the applicable Award
Agreements.

3.14 Governing Law

          All rights and obligations under the Plan shall be construed and interpreted in accordance
with the laws of the State of Delaware, without giving effect to principles of conflict of laws.

14

 

3.15 Financial Reports

          With respect to periods prior to the time that the requirements set forth in Section 25100(o)
of the California Corporations Code, to the extent applicable and as modified from time to time
(relating to securities listed on a national exchange), are not satisfied, the Company each year
shall furnish to optionees, Grantees and stockholders who have received Common Stock under the Plan
its balance sheet and income statement, unless such optionees, Grantees or stockholders are key
employees whose duties with the Company assure them access to equivalent information. Such balance
sheet and income statement need not be audited.

3.16 Severability; Entire Agreement

          If any of the provisions of this Plan or any Award Agreement is finally held to be invalid,
illegal or unenforceable (whether in whole or in part), such provision shall be deemed modified to
the extent, but only to the extent, of such invalidity, illegality or unenforceability and the
remaining provisions shall not be affected thereby; provided, that if any of such provisions is
finally held to be invalid, illegal, or unenforceable because it exceeds the maximum scope
determined to be acceptable to permit such provision to be enforceable, such provision shall be
deemed to be modified to the minimum extent necessary to modify such scope in order to make such
provision enforceable hereunder. The Plan and any Award Agreements contain the entire agreement of
the parties with respect to the subject matter thereof and supersede all prior agreements,
promises, covenants, arrangements, communications, representations and warranties between them,
whether written or oral with respect to the subject matter thereof.

3.17 Waiver of Claims

          Each grantee of an Award recognizes and agrees that prior to being selected by the Committee
to receive an Award he or she has no right to any benefits hereunder. Accordingly, in
consideration of the grantee’s receipt of any Award hereunder, he or she expressly waives any
right to contest the amount of any Award, the terms of any Award Agreement, any determination,
action or omission hereunder or under any Award Agreement by the Committee, the Company or the
Board, or any amendment to the Plan or any Award Agreement (other than an amendment to this Plan or
an Award Agreement to which his or her consent is expressly required by the express terms of the
Plan or an Award Agreement).

3.18 No Third Party Beneficiaries

          Except as expressly provided therein, neither the Plan nor any Award Agreement shall confer on
any person other than the Company and the grantee of any Award any rights or remedies thereunder.

3.19 Successors and Assigns

          The terms of this Plan shall be binding upon and inure to the benefit of the Company and its
successors and assigns.

15

 

PERLEGEN SCIENCES, INC.

2001 STOCK OPTION AND INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION AWARD AGREEMENT

          This Award Agreement (the “Agreement”) is entered into between Perlegen Sciences, Inc., a
Delaware corporation (the “Company”), and the Grantee whose name is set forth below, pursuant to
the Perlegen Sciences, Inc. 2001 Stock Option and Incentive Plan (the “Plan”). Capitalized terms
used in this Agreement and not defined herein are defined in the Plan.

ARTICLE I

Grant of Option

     Section 1.1 Grant of Option

          The Company hereby grants to the Grantee a non-qualified stock option (“Option”) to purchase
shares of the Company’s common stock (the “Common Stock”) on the terms set forth below:

	 	 	 
	Grantee
	 	 
	 
	 	 
	Capacity in Which Granted
	 	 
	 
	 	 
	Grant Date
	 	 
	 
	 	 
	Number of Shares Subject to Option
	 	 
	 
	 	 
	Exercise Price per Share
	 	 
	 
	 	 
	Expiration Date
	 	 

ARTICLE II

Vesting; Exercise; Expiration

     Section 2.1 Vesting

          The right to exercise this Option shall vest in installments as follows:

	 	 	 
	On or after:	 	This Option shall be exercisable as to:
	 

	 	25% of the total shares subject to this Option

-1-

 

	 	 	 
	On or after:	 	This Option shall be exercisable as to:
	 

	 	an additional 25% of the total shares subject to this Option
	 

	 	an additional 25% of the total shares subject to this Option
	 

	 	an additional 25% of the total shares subject to this Option

No installment of the Option shall vest after the Termination of Employment of the Grantee or
Grantee’s permanent disability or death.

     Section 2.2 Exercise

          Grantee may exercise vested options by delivering a written notice, in such form and manner
prescribed by the Company, setting forth the number of shares of Common Stock with respect to which
the Option is exercised and delivering the aggregate Exercise Price for such number of shares, in
accordance with the provisions of the Plan. An Option may be exercised only for a whole number of
shares. At the time of exercise, Grantee shall pay to the Company, or make arrangements for
payment to the satisfaction of the Company, such amount as the Company deems necessary to satisfy
its obligation to withhold Federal, state, local or other taxes incurred by reason of such
exercise.

     Section 2.3 Company Call

          During any period prior to an initial public offering of the Company’s shares of Common Stock,
the Company shall have the right, but not the obligation, to purchase during the Call Period (as
defined below) any part or all of the shares purchased by Grantee pursuant to this Option. The
“Call Period” shall be the ninety-day period following Grantee’s Termination of Employment for any
reason, provided, however that with respect to any shares purchased by Grantee pursuant to
Section 2.4(b) following Termination of Employment, the Call Period shall be the greater of (a)
ninety days following Termination of Employment, or (b) thirty days following such purchase by the
Grantee. The price per share for any purchase by the Company shall be the fair market value of the
Company’s common stock as determined by the Board of Directors of the Company, taking into
consideration such factors as the Board deems advisable, including, but not limited to, the
valuation at the Company’s most recent round of equity financing, and recent developments at the
Company and in the general industry. Payment for any shares so purchased by the Company shall be
made in a cash lump sum or pursuant to any other method agreed by the Company and Grantee.

     Section 2.4 Expiration

          This Agreement shall expire on, and the Option may not be exercised after, the earliest to
occur of the following:

	 	(a)	 	The expiration date set forth in Article I;

-2-

 

	 	(b)	 	Ninety days after the termination of employment of the Grantee
for any reason, except disability, death or by the Company for Cause;
	 
	 	(c)	 	The termination of employment of the Grantee by the Company for
Cause;
	 
	 	(d)	 	One year after the date of the disability or death of the
Grantee.

     Section 2.5 “Cause”

          “Cause” shall mean the willful and continued failure by Grantee to perform substantially his
duties with Company (other than any such failure resulting from incapacity due to physical or
mental illness) after a demand for substantial performance is delivered to Grantee by the Company
which specifically identifies the manner in which Company believes Grantee has not substantially
performed his duties; conviction of a felony; habitual abuse of narcotics or alcohol; or fraud,
material dishonesty or gross misconduct in connection with the business of the Company.

ARTICLE III

     Section 3.1 Non-transferability of Option

          The Option and rights granted hereunder shall not be transferred, assigned, pledged or
exchanged in any manner whatsoever, whether voluntarily or involuntarily, by the Grantee, otherwise
than by will or the laws of descent and distribution or to an immediate family member (as defined
in the Plan), and is exercisable during the Employee’s lifetime only by the Employee or by the
Employee’s legal representative or such immediate family member.

     Section 3.2 Securities Law Matters

	 	(a)	 	Upon each issuance of shares of stock following proper exercise by Grantee, the
Grantee, a transferee permitted under Section 3.1, or Grantee’s legal representative,
or heirs receiving the shares, shall, if requested by the Company in order to comply
with federal or state securities laws, represent in writing to the Company that such
shares are being acquired for investment and with no view to any distribution thereof
or shall make such other representations in writing to the Company, with respect to the
further transfer of such shares, as may be deemed by the Company to be necessary or
desirable under the applicable securities laws. The Company, at its sole discretion,
may take all reasonable steps, including the affixing of a legend on certificates
issued in connection with such shares of stock, or the imposition of stop-transfer
instructions, to achieve compliance.
	 
	 	(b)	 	Grantee hereby agrees to subject any shares purchased pursuant to this Option
to a lock-up period of up to 12 months if requested by the Company, pursuant to a
request by the underwriters, in connection with and following any underwritten

-3-

 

	 	 	 	public offering of equity securities.

     Section 3.3 Incorporation of Plan by Reference; Supremacy of Plan Provisions

          The Plan is hereby incorporated into this Agreement by reference to the same extent as though
it were set forth in full herein. If there is any conflict between the provisions of the Plan and
any provision of this Agreement, this Agreement shall be construed and enforced in accordance with
the provisions of the Plan and this Agreement without regard to the conflicting provision of the
Agreement.

     Section 3.4 Merger or Sale of Company

          In the event of (i) a merger or consolidation of the Company with or into any other
corporation or entity, (ii) a sale of all or substantially all of the Company’s assets to any other
corporation or entity or (iii) any transaction by which another person, corporation or entity
(other than Affymetrix and any corporation or entity in which Affymetrix holds a controlling
interest, directly or indirectly) becomes the Beneficial Owner of more than 50% of the issued and
outstanding Shares of the Company, outstanding Options shall be treated as set forth in Section 3.7
of the Plan.

-4-

 

Executed as of the Grant Date:

	 	 	 	 	 	 	 	 	 
	 	 	Perlegen Sciences, Inc.	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	Grantee
	 	 

-5-

 

PERLEGEN SCIENCES, INC.

2001 STOCK OPTION AND INCENTIVE PLAN

INCENTIVE STOCK OPTION AWARD AGREEMENT

          This Award Agreement (the “Agreement”) is entered into between Perlegen Sciences, Inc., a
Delaware corporation (the “Company”), and the Grantee whose name is set forth below, pursuant to
the Perlegen Sciences, Inc. 2001 Stock Option and Incentive Plan (the “Plan”). Capitalized terms
used in this Agreement and not defined herein are defined in the Plan.

ARTICLE I

Grant of Option

     Section 1.1 Grant of Option

          The Company hereby grants to the Grantee an option intended to qualify as an incentive stock
option under Section 422 of the Code (“Option”) to purchase shares of the Company’s common stock
(the “Common Stock”) on the terms set forth below:

	 	 	 
	Grantee
	 	 
	 
	 	 
	Capacity in Which Granted
	 	 
	 
	 	 
	Grant Date
	 	 
	 
	 	 
	Number of Shares Subject to Option
	 	 
	 
	 	 
	Exercise Price per Share
	 	 
	 
	 	 
	Expiration Date
	 	 

To the extent the exercise of this Option fails to qualify, for whatever reason, as the exercise of
an incentive stock option, it will be considered the exercise of a non-qualified stock option.

ARTICLE II

Vesting; Exercise; Expiration

     Section 2.1 Vesting

          The right to exercise this Option shall vest in installments as follows:

	 	 	 
	On or after:	 	This Option shall be exercisable as to:
	 

	 	25% of the total shares subject to this Option

-1-

 

	 	 	 
	On or after:	 	This Option shall be exercisable as to:
	 

	 	an additional 25% of the total shares subject to this Option
	 

	 	an additional 25% of the total shares subject to this Option
	 

	 	an additional 25% of the total shares subject to this Option

No installment of the Option shall vest after the Termination of Employment of the Grantee or
Grantee’s permanent disability or death.

     Section 2.2 Exercise

          Grantee may exercise vested options by delivering a written notice, in such form and manner
prescribed by the Company, setting forth the number of shares of Common Stock with respect to which
the Option is exercised and delivering the aggregate Exercise Price for such number of shares, in
accordance with the provisions of the Plan. An Option may be exercised only for a whole number of
shares. At the time of exercise, Grantee shall pay to the Company, or make arrangements for
payment to the satisfaction of the Company, such amount as the Company deems necessary to satisfy
its obligation to withhold Federal, state, local or other taxes incurred by reason of such
exercise.

     Section 2.3 Company Call

          During any period prior to an initial public offering of the Company’s shares of Common Stock,
the Company shall have the right, but not the obligation, to purchase during the Call Period (as
defined below) any part or all of the shares purchased by Grantee pursuant to this Option. The
“Call Period” shall be the ninety-day period following Grantee’s Termination of Employment for any
reason, provided, however that with respect to any shares purchased by Grantee pursuant to
Section 2.4(b) following Termination of Employment, the Call Period shall be the greater of (a)
ninety days following Termination of Employment, or (b) thirty days following such purchase by the
Grantee. The price per share for any purchase by the Company shall be the fair market value of the
Company’s common stock as determined by the Board of Directors of the Company, taking into
consideration such factors as the Board deems advisable, including, but not limited to, the
valuation at the Company’s most recent round of equity financing, and recent developments at the
Company and in the general industry. Payment for any shares so purchased by the Company shall be
made in a cash lump sum or pursuant to any other method agreed by the Company and Grantee.

     Section 2.4 Expiration

          This Agreement shall expire on, and the Option may not be exercised after, the earliest to
occur of the following:

	 	(a)	 	The expiration date set forth in Article I;

-2-

 

	 	(b)	 	Ninety days after the termination of employment of the Grantee
for any reason, except disability, death or by the Company for Cause;
	 
	 	(c)	 	The termination of employment of the Grantee by the Company for
Cause;
	 
	 	(d)	 	One year after the date of the disability or death of the
Grantee.

     Section 2.5 “Cause”

          “Cause” shall mean the willful and continued failure by Grantee to perform substantially his
duties with Company (other than any such failure resulting from incapacity due to physical or
mental illness) after a demand for substantial performance is delivered to Grantee by the Company
which specifically identifies the manner in which Company believes Grantee has not substantially
performed his duties; conviction of a felony; habitual abuse of narcotics or alcohol; or fraud,
material dishonesty or gross misconduct in connection with the business of the Company.

ARTICLE III

     Section 3.1 Non-transferability of Option

          The Option and rights granted hereunder shall not be transferred, assigned, pledged or
exchanged in any manner whatsoever, whether voluntarily or involuntarily, by the Grantee, otherwise
than by will or the laws of descent and distribution or to an immediate family member (as defined
in the Plan), and is exercisable during the Employee’s lifetime only by the Employee or by the
Employee’s legal representative or such immediate family member.

     Section 3.2 Securities Law Matters

	 	(a)	 	Upon each issuance of shares of stock following proper exercise by Grantee, the
Grantee, a transferee permitted under Section 3.1, or Grantee’s legal representative,
or heirs receiving the shares, shall, if requested by the Company in order to comply
with federal or state securities laws, represent in writing to the Company that such
shares are being acquired for investment and with no view to any distribution thereof
or shall make such other representations in writing to the Company, with respect to the
further transfer of such shares, as may be deemed by the Company to be necessary or
desirable under the applicable securities laws. The Company, at its sole discretion,
may take all reasonable steps, including the affixing of a legend on certificates
issued in connection with such shares of stock, or the imposition of stop-transfer
instructions, to achieve compliance.
	 
	 	(b)	 	Grantee hereby agrees to subject any shares purchased pursuant to this Option
to a lock-up period of up to 12 months if requested by the Company, pursuant to a
request by the underwriters, in connection with and following any underwritten

-3-

 

	 	 	 	public offering of equity securities.

     Section 3.3 Incorporation of Plan by Reference; Supremacy of Plan Provisions

          The Plan is hereby incorporated into this Agreement by reference to the same extent as though
it were set forth in full herein. If there is any conflict between the provisions of the Plan and
any provision of this Agreement, this Agreement shall be construed and enforced in accordance with
the provisions of the Plan and this Agreement without regard to the conflicting provision of the
Agreement.

     Section 3.4 Merger or Sale of Company

          In the event of (i) a merger or consolidation of the Company with or into any other
corporation or entity, (ii) a sale of all or substantially all of the Company’s assets to any other
corporation or entity or (iii) any transaction by which another person, corporation or entity
(other than Affymetrix and any corporation or entity in which Affymetrix holds a controlling
interest, directly or indirectly) becomes the Beneficial Owner of more than 50% of the issued and
outstanding Shares of the Company, outstanding Options shall be treated as set forth in Section 3.7
of the Plan.

-4-

 

Executed as of the Grant Date:

	 	 	 	 	 	 	 	 	 
	 	 	Perlegen Sciences, Inc.	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	Grantee
	 	 

-5-

 

PERLEGEN SCIENCES, INC.

2001 EQUITY INCENTIVE PLAN

EXERCISE NOTICE

Perlegen Sciences, Inc.

2021 Stierlin Court

Mountain View, CA 94043

Attention: Frank Zampella

     1. Exercise of Option. Effective as of today, ___, ___, the undersigned
(“Optionee”) hereby elects to exercise Optionee’s option to purchase ___shares of the Common
Stock (the “Shares”) of Perlegen Sciences, Inc. (the “Company”) under and pursuant to the Perlegen
Sciences, Inc. 2001 Equity Incentive Plan (the “Plan”) and
the o Incentive
o Non-Qualified Stock Option
Agreement dated ___, ___, (the “Option Agreement”).

	 	 	 	 	 
	Date of Grant:
	 	 	 	                                                            
	 
	 	 	 	 
	Number of Shares as to which Option is Exercised:
	 	 	 	                                                            
	 
	 	 	 	 
	Exercise Price per Share:
	 	 	 	$                    
	 
	 	 	 	 
	Total Exercise Price:
	 	 	 	$                    
	 
	 	 	 	 
	Certificate to be issued in name of:
	 	 	 	                                                            
	 
	 	 	 	 
	Cash Payment delivered herewith:
	 	o	 	$                    
	 
	 	 	 	 
	Promissory note delivered herewith:
	 	o	 	$                    

	 	 	 	 	 
	Type of Option:

	 	o Incentive Stock Option
	 	o Non-Qualified Stock Option

     2. Representations of Optionee. Optionee acknowledges that Optionee has received,
read and understood the Plan and the Option Agreement. Optionee agrees to abide by and be bound by
their terms and conditions.

     3. Rights as Stockholder. Until the stock certificate evidencing such Shares is
issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized
transfer agent of the Company), no right to vote or receive dividends or any other rights as a
stockholder shall exist with respect to Shares subject to the Option, notwithstanding the exercise
of the Option. The Company shall issue (or cause to be issued) such stock certificate promptly
after the Option is exercised. No adjustment will be made for a dividend or other right for which
the record date is prior to the date the stock certificate is issued, except as provided in Section
13 of the Plan.

     Optionee shall enjoy rights as a stockholder until such time as Optionee disposes of the
Shares or the Company and/or its assignee(s) exercises the Right of First Refusal

 

 

hereunder. Upon such exercise, Optionee shall have no further rights as a holder of the
Shares so purchased except the right to receive payment for the Shares so purchased in accordance
with the provisions of this Agreement, and Optionee shall forthwith cause the certificate(s)
evidencing the Shares so purchased to be surrendered to the Company for transfer or cancellation.

     4. Optionee’s Rights to Transfer Shares.

          (a) Company’s Right of First Refusal. Before any Shares held by Optionee or any
permitted transferee (each, a “Holder”) may be sold, pledged, assigned, hypothecated, transferred,
or otherwise disposed of (each, a “Transfer”), the Company or its assignee(s) shall have a right of
first refusal to purchase the Shares on the terms and conditions set forth in this Section (the
“Right of First Refusal”).

               (i) Notice of Proposed Transfer. The Holder of the Shares shall deliver to the
Company a written notice (the “Notice”) stating: (i) the Holder’s bona fide intention to sell or
otherwise Transfer such Shares; (ii) the name of each proposed purchaser or other transferee
(“Proposed Transferee”); (iii) the number of Shares to be Transferred to each Proposed Transferee;
and (iv) the bona fide cash price or other consideration for which the Holder proposes to Transfer
the Shares (the “Offered Price”), and the Holder shall offer the Shares at the Offered Price to the
Company or its assignee(s).

               (ii) Exercise of Right of First Refusal. Within thirty (30) days after receipt of the
Notice, the Company and/or its assignee(s) may elect in writing to purchase all, but not less than
all, of the Shares proposed to be Transferred to any one or more of the Proposed Transferees. The
purchase price will be determined in accordance with subsection (c) below.

               (iii) Purchase Price. The purchase price (“Purchase Price”) for the Shares
repurchased under this Section shall be the Offered Price. If the Offered Price includes
consideration other than cash, the cash equivalent value of the non-cash consideration shall be
determined by the Board of Directors of the Company in good faith.

               (iv) Payment. Payment of the Purchase Price shall be made, at the option of the
Company or its assignee(s), in cash (by check), by cancellation of all or a portion of any
outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an
assignee, to the assignee), or by any combination thereof within thirty (30) days after receipt of
the Notice or in the manner and at the times set forth in the Notice.

               (v) Holder’s Right to Transfer. If all of the Shares proposed in the Notice to be
transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s)
as provided in this Section, then the Holder may sell or otherwise Transfer such Shares to that
Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other
Transfer is consummated within one hundred twenty (120) days after the date of the Notice and
provided further that any such sale or other Transfer is effected in accordance with any applicable
securities laws and the Proposed Transferee agrees in writing that the provisions of this Section
shall continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares
described in the Notice are not Transferred to the Proposed Transferee within such period, a new
Notice shall be given to the Company, and the Company and/or its

2

 

assignees shall again be offered the Right of First Refusal as provided herein before any
Shares held by the Holder may be sold or otherwise Transferred.

          (b) Exception for Certain Family Transfers. Anything to the contrary contained in
this Section notwithstanding, the Transfer of any or all of the Shares during the Optionee’s
lifetime or on the Optionee’s death by will or intestacy to the Optionee’s Immediate Family or a
trust for the benefit of the Optionee’s Immediate Family shall be exempt from the Right of First
Refusal. As used herein, “Immediate Family” shall mean spouse, lineal descendant or antecedent,
father, mother, brother or sister or stepchild (whether or not adopted). In such case, the
transferee or other recipient shall receive and hold the Shares so Transferred subject to the
provisions of this Section (including the Right of First Refusal) and there shall be no further
Transfer of such Shares except in accordance with the terms of this Section.

     5. Termination of Right of First Refusal. The Right of First Refusal shall terminate
as to all Shares upon a sale of Common Stock of the Company to the general public pursuant to a
registration statement filed with and declared effective by the Securities and Exchange Commission
under the Securities Act of 1933, as amended (a “Public Offering”).

     6. Tax Consultation. Optionee understands that Optionee may suffer adverse tax
consequences as a result of Optionee’s purchase or disposition of the Shares. Optionee represents
that Optionee has consulted with any tax consultants Optionee deems advisable in connection with
the purchase or disposition of the Shares and that Optionee is not relying on the Company for any
tax advice.

     7. Restrictive Legends and Stop-Transfer Orders.

          (a) Legends. Optionee understands and agrees that the Company shall cause the legends
set forth below or legends substantially equivalent thereto, to be placed upon any certificate(s)
evidencing ownership of the Shares together with any other legends that may be required by state or
federal securities laws:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE OFFERED, SOLD OR
OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL
REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH
OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH.

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN
RESTRICTIONS ON TRANSFER AND RIGHT OF FIRST REFUSAL OPTIONS HELD BY
THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE
BETWEEN THE ISSUER AND THE

3

 

ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT
THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND
RIGHT OF FIRST REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES.

          (b) Stop-Transfer Notices. Optionee agrees that, in order to ensure compliance with
the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions
to its transfer agent, if any, and that, if the Company transfers its own securities, it may make
appropriate notations to the same effect in its own records.

          (c) Refusal to Transfer. The Company shall not be required (i) to transfer on its
books any Shares that have been sold or otherwise transferred in violation of any of the provisions
of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay
dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

     8. Successors and Assigns. The Company may assign any of its rights under this
Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the
successors and assigns of the Company. Subject to the restrictions on transfer herein set forth,
this Agreement shall be binding upon Optionee and his or her heirs, executors, administrators,
successors and assigns.

     9. Interpretation. Any dispute regarding the interpretation of this Agreement shall
be submitted by Optionee or by the Company forthwith to the Company’s Board of Directors or
committee thereof that is responsible for the administration of the Plan (the “Administrator”),
which shall review such dispute at its next regular meeting. The resolution of such a dispute by
the Administrator shall be final and binding on the Company and on Optionee.

     10. Governing Law; Severability. This Agreement shall be governed by and construed in
accordance with the laws of the State of California excluding that body of law pertaining to
conflicts of law. Should any provision of this Agreement be determined by a court of law to be
illegal or unenforceable, the other provisions shall nevertheless remain effective and shall remain
enforceable.

     11. Notices. Any notice required or permitted hereunder shall be given in writing and
shall be deemed effectively given upon personal delivery or upon deposit in the United States mail
by certified mail, with postage and fees prepaid, addressed to the other party at its address as
shown below beneath its signature, or to such other address as such party may designate in writing
from time to time to the other party.

     12. Further Instruments. The parties agree to execute such further instruments and to
take such further action as may be reasonably necessary to carry out the purposes and intent of
this Agreement.

     13. Delivery of Payment. Optionee herewith delivers to the Company the full Exercise
Price for the Shares, as well as any applicable withholding tax.

4

 

     14. Entire Agreement. The Plan and Stock Option Agreement are incorporated herein by
reference. This Agreement, the Plan, the Stock Option Agreement and the Investment Representation
Statement constitute the entire agreement of the parties and supersede in their entirety all prior
undertakings and agreements of the Company and Optionee with respect to the subject matter hereof.

	 	 	 	 	 	 	 	 	 
	Accepted by:	 	 	 	Submitted by:
	 
	 	 	 	 	 	 	 	 
	PERLEGEN SCIENCES, INC.	 	 	 	OPTIONEE
	 
	 	 	 	 	 	 	 	 
	By:
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Name:	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Its:
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	Address:
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 

5

 

EXHIBIT B

INVESTMENT REPRESENTATION STATEMENT

	 	 	 	 	 
	OPTIONEE

	 	:	 	 
	 
	 	 	 	 
	COMPANY

	 	:
	 	PERLEGEN SCIENCES, INC.
	 
	 	 	 	 
	SECURITY

	 	:
	 	COMMON STOCK
	 
	 	 	 	 
	AMOUNT

	 	:	 	 
	 
	 	 	 	 
	DATE

	 	:	 	 

     In connection with the purchase of the above-listed Securities, the undersigned Optionee
represents to the Company the following:

          (a) Optionee is aware of the Company’s business affairs and financial condition and has
acquired sufficient information about the Company to reach an informed and knowledgeable decision
to acquire the Securities. Optionee is acquiring these Securities for investment for Optionee’s
own account only and not with a view to, or for resale in connection with, any “distribution”
thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).

          (b) Optionee acknowledges and understands that the Securities constitute “restricted
securities” under the Securities Act and have not been registered under the Securities Act in
reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the
bona fide nature of Optionee’s investment intent as expressed herein. In this connection, Optionee
understands that, in the view of the Securities and Exchange Commission, the statutory basis for
such exemption may be unavailable if Optionee’s representation was predicated solely upon a present
intention to hold these Securities for the minimum capital gains period specified under tax
statutes, for a deferred sale, for or until an increase or decrease in the market price of the
Securities, or for a period of one year or any other fixed period in the future. Optionee further
understands that the Securities must be held indefinitely unless they are subsequently registered
under the Securities Act or an exemption from such registration is available. Optionee further
acknowledges and understands that the Company is under no obligation to register the Securities.
Optionee understands that the certificate evidencing the Securities will be imprinted with a legend
which prohibits the transfer of the Securities unless they are registered or such registration is
not required in the opinion of counsel satisfactory to the Company and any other legend required
under applicable state securities laws.

          (c) Optionee is familiar with the provisions of Rule 701 and Rule 144, each promulgated under
the Securities Act, which, in substance, permit limited public resale of “restricted securities”
acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to 

 

 

the
satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701
at the time of the grant of the Option to the Optionee, the exercise will be exempt from
registration under the Securities Act. In the event the Company becomes subject to the reporting
requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days
thereafter (or such longer period as any market stand-off agreement may require) the Securities
exempt under Rule 701 may be resold, subject to the satisfaction of certain of the conditions
specified by Rule 144, including: (1) the resale being made through a broker in an unsolicited
“broker’s transaction” or in transactions directly with a market maker (as said term is defined
under the Securities Exchange Act of 1934); and, in the case of an affiliate, (2) the availability
of certain public information about the Company, (3) the amount of Securities being sold during any
three (3) month period not exceeding the limitations specified in Rule 144(e), and (4) the timely
filing of a Form 144, if applicable.

          In the event that the Company does not qualify under Rule 701 at the time of grant of the
Option, then the Securities may be resold in certain limited circumstances subject to the
provisions of Rule 144, which requires the resale to occur not less than one year after the later
of the date the Securities were sold by the Company or the date the Securities were sold by an
affiliate of the Company, within the meaning of Rule 144; and, in the case of acquisition of the
Securities by an affiliate, or by a non-affiliate who subsequently holds the Securities less than
two (2) years, the satisfaction of the conditions set forth in sections (1), (2), (3) and (4) of
the paragraph immediately above.

          (d) Optionee further understands that in the event all of the applicable requirements of Rule
701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A,
or some other registration exemption will be required; and that, notwithstanding the fact that
Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has
expressed its opinion that persons proposing to sell private placement securities other than in a
registered offering and otherwise than pursuant to Rules 144 or 701 will have a substantial burden
of proof in establishing that an exemption from registration is available for such offers or sales,
and that such persons and their respective brokers who participate in such transactions do so at
their own risk. Optionee understands that no assurances can be given that any such other
registration exemption will be available in such event.

	 	 	 
	 

	 	Signature of Optionee:
	 
	 	 
	 

	 	 

Date:                                         , ____

1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]